Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer

Anti-Cancer Agents in Medicinal Chemistry, 14(2): 256-264.

Author(s): Kui Ma and Ya H Tang.

Affiliation: LSU Health Sciences Center, School of Medicine, 1501 Kings Hwy, P.O. Box 33932, Shreveport, LA 71130, USA.


Traditional anti-cancer therapies (surgery, radiotherapy and chemotherapy) have limited effectiveness in curbing progression of advanced tumors. However, with advances in immunology and molecular biology in the last two decades, the prognosis of cancer immunotherapy has improved. An emerging therapy is the cancer vaccine as adjunctive therapy. The purpose of this paper is to review this therapeutic modality for non-small cell lung cancer.


Immunotherapy, MAGE-A3, MUC1, non-small cell lung cancer, tumor antigens, vaccine.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 2
First Page: 256
Last Page: 264
Page Count: 9
DOI: 10.2174/18715206113136660378
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science